0000950123-21-002372.txt : 20210216
0000950123-21-002372.hdr.sgml : 20210216
20210216072908
ACCESSION NUMBER: 0000950123-21-002372
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210216
DATE AS OF CHANGE: 20210216
EFFECTIVENESS DATE: 20210216
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABG Innovation Capital Partners III GP Ltd
CENTRAL INDEX KEY: 0001845297
IRS NUMBER: 000000000
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20837
FILM NUMBER: 21632432
BUSINESS ADDRESS:
STREET 1: 15 QUEENS ROAD CENTRAL, UNIT 3002-3004
STREET 2: 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK
CITY: HONG KONG
STATE: F4
ZIP: 0000000000
BUSINESS PHONE: 852 31219699
MAIL ADDRESS:
STREET 1: 15 QUEENS ROAD CENTRAL, UNIT 3002-3004
STREET 2: 30TH FLOOR, GLOUCESTER TWR, THE LANDMARK
CITY: HONG KONG
STATE: F4
ZIP: 0000000000
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001845297
XXXXXXXX
12-31-2020
12-31-2020
false
ABG Innovation Capital Partners III GP Ltd
15 QUEEN'S ROAD CENTRAL, UNIT 3002-3004
30TH FLOOR, GLOUCESTER TWR, THE LANDMARK
HONG KONG
F4
0000000000
13F HOLDINGS REPORT
028-20837
N
Fan Yu
Director
852 31219699
/s/ Fan Yu
Cannes
I0
02-16-2021
1
7
169844
false
1
Fan Yu
INFORMATION TABLE
2
2781.xml
INFORMATION TABLE FOR FORM 13F
AERPIO PHARMACEUTICALS INC
COM
00810B105
392
400000
SH
DFND
1
400000
0
0
ATEA PHARMACEUTICALS INC
COM
04683R106
110265
2639178
SH
DFND
1
2639178
0
0
IDERA PHARMACEUTICALS INC
COM PAR
45168K405
206
56250
SH
DFND
1
56250
0
0
GENOCEA BIOSCIENCES INC
COM NEW
372427401
908
375000
SH
DFND
1
375000
0
0
NABRIVA THERAPEUTICS PLC
SHS NEW
G63637113
111
45849
SH
DFND
1
45849
0
0
PULMONX CORP
COM
745848101
57517
833333
SH
DFND
1
833333
0
0
SYNLOGIC INC
COM
87166L100
445
205906
SH
DFND
1
205906
0
0